Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex (1985)
- Authors:
- Autor USP: ARACAVA, YASCO - ICB
- Unidade: ICB
- Subjects: FARMACOLOGIA; CANAIS IÔNICOS; ACETILCOLINA; RECEPTORES DE ACETILCOLINA
- Language: Português
- Source:
- Título: Molecular Pharmacology
- Volume/Número/Paginação/Ano: v. 28, p. 527-538, 1985
-
ABNT
SHAW, K. P. et al. Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex. Molecular Pharmacology, v. 28, p. 527-538, 1985Tradução . . Acesso em: 18 mar. 2026. -
APA
Shaw, K. P., Aracava, Y., Akaike, A., Dely, J. W., Rickett, D. L., & Albuquerque, E. X. (1985). Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex. Molecular Pharmacology, 28, 527-538. -
NLM
Shaw KP, Aracava Y, Akaike A, Dely JW, Rickett DL, Albuquerque EX. Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex. Molecular Pharmacology. 1985 ; 28 527-538.[citado 2026 mar. 18 ] -
Vancouver
Shaw KP, Aracava Y, Akaike A, Dely JW, Rickett DL, Albuquerque EX. Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex. Molecular Pharmacology. 1985 ; 28 527-538.[citado 2026 mar. 18 ]
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
